Course faculty will be one of the following instructors.
George H. D’Addamio, PhD, is President of PharmConsult, Inc., a consulting company in Atlanta, GA. During 8 years at SmithKline & French Laboratories (now Glaxo SmithKline), Dr. D’Addamio was responsible for preparing protocols, case report forms, integrated study reports, and regulatory submissions in Clinical R&D and Medical Affairs. As Scientific Manager, Clinical R&D, he was responsible for coordinating clinical research programs in Canada, Latin America, and the Pacific conducted under the US IND. In Medical Affairs, he managed operational groups responsible for medical writing, clinical monitoring, and safety reviews and quality control checks of CRFs. After leaving SK&F, Dr. D’Addamio worked for a CRO for 1.5 years before forming PharmConsult in 1987. Previous consulting experience includes project management, data management, statistical services, and medical writing. Currently, PharmConsult specializes in preparation of clinical development documents in various therapeutic areas for domestic and foreign pharmaceutical companies.
Kathi Durdon
Kathi Durdon is Executive Director of the Central New York Biotech Accelerator (CNYBAC) located in Syracuse, NY managing facility operations; pharmaceutical, biologic and medical device client needs; and collaborative partnership programs. Kathi serves as a Board Member for both MedTech, a non-profit trade organization, and the Business Incubator Association of New York State (BIANYS) and is an Adjunct Assistant Professor at Upstate Medical University. Previously, Kathi was the Clinical Affairs Manager at Welch Allyn, a medical device manufacturer (now Hillrom), and Director of Clinical Trials at Upstate Medical University.
Carolyn E. Rugloski
Ms. Rugloski, MS, has over 30 years of clinical trial research experience working within pharmaceutical, biopharmaceutical, university, and CRO environments and has provided her expertise to functional-area managerial leadership in areas of data management, monitoring, training, project management, quality assurance, and business development.
Since 2008, she has served in senior project manager positions working for global CROs, MedImmune, UCSF ITN and Duke DCRI. She has dedicated her volunteer time over the years to the training of clinical trial professionals through SOCRA and other educational organizations. Recognized internationally as a Good Clinical Practice (GCP) Trainer and subject matter expert, Ms. Rugloski has consulted and lectured in North America, South America, Europe, and Asia. Ms. Rugloski is a past member of the SOCRA Board of Directors and continues to assist in the development and delivery of SOCRA events.